High international prognostic score predicts a worse outcome for patients with Hodgkin's disease and HIV infection: Results of a prospective study with Stanford V regimen [1]

Annals of Oncology

Volumn 14, Issue 4, 2003, Pages 655-656

  Spina, M ^a   Re, A ^b   Vaccher, E ^a   Gabarre, J ^c   Tirelli, U ^a  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^b Civil Hospital   (Italy)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PREDNISONE; ANTINEOPLASTIC AGENT;

BONE MARROW TOXICITY; CANCER REGRESSION; CANCER SURVIVAL; CONSTIPATION; FOLLOW UP; HISTOLOGY; HODGKIN DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; LYMPHOCYTE DEPLETION; MULTIVARIATE ANALYSIS; PARESTHESIA; PRIORITY JOURNAL; PROGNOSIS; SCORING SYSTEM; ADULT; CANCER STAGING; DISEASE COURSE; FEMALE; MALE; MIDDLE AGED; PATHOLOGY; PROSPECTIVE STUDY; RADIOTHERAPY; SURVIVAL; VIROLOGY;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DISEASE PROGRESSION; FEMALE; HIV INFECTIONS; HODGKIN DISEASE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PROGNOSIS; PROSPECTIVE STUDIES; RADIOTHERAPY; SURVIVAL;

EID: 0037819316     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/mdg152     Document Type: Letter

References (4)

1. Horning SJ, Hoppe RT, Breslin S et al. Stanford V and radiotherapy for locally and advanced Hodgkin's disease: mature results of a prospective clinical trial. J Clin Oncol 2002; 20: 630-637.
2. Errante D, Tirelli U, Gastaldi R et al. Combined antineoplastic and antiretroviral therapy for patients with Hodgkin's disease and human immunodeficiency virus infection. A prospective study of 17 patients. The Italian Cooperative Group on AIDS and Tumors (GICAT). Cancer 1994; 73: 437-444.
3. Errante D, Gabarre J, Ridolfo AL et al. Hodgkin's disease in 35 patients with HIV infection: an experience with epirubicin, bleomycin, vinblastine and prednisone chemotherapy in combination with antiretroviral therapy and primary use of G-CSF. Ann Oncol 1999; 10: 189-195.
4. Levine AM, Li P, Cheung T et al. Chemotherapy consisting of doxorubicin, bleomycin, vinblastine, and decarbazine with granulocyte-colony-stimulating factor in HIV-infected patients with newly diagnosed Hodgkin's disease: a prospective, multi-institutional AIDS clinical trials group study (ACTG 149). J Acquir Imm Defic Syndr 2000; 24: 444-450.